Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

Clinical trial NCT05285826 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05285826
Sponsor: Merck Sharp & Dohme LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Papillomavirus Infections

Start date: 2022-02-18
Primary completion: 2029-05-25
Enrollment: 8100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.